Stock Traders Purchase Large Volume of Call Options on SIGA Technologies (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGA) was the target of some unusual options trading on Wednesday. Investors purchased 1,200 call options on the company. This is an increase of approximately 1,438% compared to the average volume of 78 call options.

Institutional Investors Weigh In On SIGA Technologies

Several institutional investors and hedge funds have recently added to or reduced their stakes in SIGA. Larson Financial Group LLC acquired a new stake in shares of SIGA Technologies in the third quarter valued at about $30,000. DekaBank Deutsche Girozentrale bought a new position in SIGA Technologies in the second quarter valued at approximately $40,000. EP Wealth Advisors LLC acquired a new position in shares of SIGA Technologies during the 3rd quarter worth approximately $82,000. XTX Topco Ltd acquired a new position in shares of SIGA Technologies during the 3rd quarter worth approximately $85,000. Finally, China Universal Asset Management Co. Ltd. raised its stake in shares of SIGA Technologies by 64.3% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company’s stock worth $93,000 after purchasing an additional 5,372 shares in the last quarter. 55.40% of the stock is owned by institutional investors.

SIGA Technologies Stock Performance

NASDAQ SIGA opened at $6.28 on Friday. SIGA Technologies has a 52 week low of $4.26 and a 52 week high of $12.83. The stock’s 50 day moving average price is $6.55 and its two-hundred day moving average price is $7.62. The stock has a market capitalization of $448.42 million, a price-to-earnings ratio of 5.23 and a beta of 0.94.

SIGA Technologies (NASDAQ:SIGA) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.02 EPS for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. The business had revenue of $10.01 million for the quarter. On average, equities research analysts forecast that SIGA Technologies will post 1.04 EPS for the current year.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.